In this section

Clinical Photonics

We use light to develop advanced diagnostic tools, wearable sensors, and microscale robots for studying diseases and enabling minimally invasive treatments.

Head of Group

Dr Alex Thompson

Office B411, Bessemer Building,
South Kensington Campus

⇒ X @_Thompson_Alex

What we do

We use photonics to develop new technologies for medicine and to study the pathophysiology of disease. This includes new and improved diagnostic tools as well as microscale robotic devices for therapeutic applications. We use a variety of optical techniques for this purpose such as fluorescence, Raman and diffuse reflectance spectroscopy, as well as microscopy and interferometry. We develop devices ranging from wearable sensors and fibre-optic probes for minimally invasive diagnostics through to microscale robots for cellular-scale manipulation and therapy.

Why it is important?

Our research has a number of potential clinical applications including improved monitoring of clinical therapies and interventions (e.g. in inflammatory bowel disease and malnutrition), early diagnosis of infection, and even margin mapping in tumour resection surgery.

How can it benefit patients?

The devices we are developing can potentially provide less invasive and lower cost diagnostics. In turn, this may facilitate patient benefits including earlier diagnosis, earlier identification of relapse (e.g. in therapy response monitoring applications), more widespread deployment and more comfortable patient experiences (e.g. through use of less invasive probes and sensors).

Meet the team

Dr Belal Ahmad
Imperial College Research Fellow

Dr Qian Chen
Clinical Research Fellow

Dr Ahmed Ezzat
Research Postgraduate

Dr Nilanjan Mandal
Research Associate in Optical Sensing for LMICs

Dr Alexander J Thompson
Senior Lecturer in Biomedical Sensing

Mr Zeyu Wang
Research Postgraduate

Citation

BibTex format

@inproceedings{Thompson:2010:10.1016/S0168-8278(10)61206-8,
author = {Thompson, AJ and Fellay, J and Ge, D and Urban, T and Shianna, K and Sulkowski, M and Muir, A and Afdhal, N and Jacobson, I and Esteban, R and Poordad, F and Lawitz, E and Mc, Cone J and Shiffman, M and Galler, G and Lee, W and Reindollar, R and King, J and Kwo, P and Ghalib, R and Freilich, B and Nyberg, L and Patel, K and Tillmann, H and Noviello, S and Bopari, N and Koury, K and Pedicone, L and Brass, C and Albrecht, JK and Goldstein, D and Mc, Hutchison JG},
doi = {10.1016/S0168-8278(10)61206-8},
pages = {S470--S470},
publisher = {ELSEVIER SCIENCE BV},
title = {GENOME WIDE ANALYSIS OF PATIENTS FROM THE IDEAL STUDY IDENTIFIES A CAUSAL ROLE FOR ITPA GENETIC VARIATION IN RIBAVIRIN-INDUCED HEMOLYTIC ANEMIA},
url = {http://dx.doi.org/10.1016/S0168-8278(10)61206-8},
year = {2010}
}

Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Thompson,AJ
AU  - Fellay,J
AU  - Ge,D
AU  - Urban,T
AU  - Shianna,K
AU  - Sulkowski,M
AU  - Muir,A
AU  - Afdhal,N
AU  - Jacobson,I
AU  - Esteban,R
AU  - Poordad,F
AU  - Lawitz,E
AU  - Mc,Cone J
AU  - Shiffman,M
AU  - Galler,G
AU  - Lee,W
AU  - Reindollar,R
AU  - King,J
AU  - Kwo,P
AU  - Ghalib,R
AU  - Freilich,B
AU  - Nyberg,L
AU  - Patel,K
AU  - Tillmann,H
AU  - Noviello,S
AU  - Bopari,N
AU  - Koury,K
AU  - Pedicone,L
AU  - Brass,C
AU  - Albrecht,JK
AU  - Goldstein,D
AU  - Mc,Hutchison JG
DO  - 10.1016/S0168-8278(10)61206-8
EP  - 470
PB  - ELSEVIER SCIENCE BV
PY  - 2010///
SN  - 0168-8278
SP  - 470
TI  - GENOME WIDE ANALYSIS OF PATIENTS FROM THE IDEAL STUDY IDENTIFIES A CAUSAL ROLE FOR ITPA GENETIC VARIATION IN RIBAVIRIN-INDUCED HEMOLYTIC ANEMIA
UR  - http://dx.doi.org/10.1016/S0168-8278(10)61206-8
ER  -